Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Hahn

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1972
Cardiovascular effects of veronamineR A Hahn, M G Kelly, M Shamma, et al.
The Journal of Cell Biology|December 1, 1996
Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphologyJ K Marchant, R A Hahn, T F Linsenmayer, et al.
Biochemical Pharmacology|October 1, 1984
Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)R W Fuller, R A Hahn, H D Snoddy, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 1, 1996
Characterization of collagen fibril segments from chicken embryo cornea, dermis and tendonD E Birk, R A Hahn, C Y Linsenmayer, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonistR A Hahn, J R Wardell, H M Sarau, et al.
JAMA|November 28, 1990
Excess deaths from nine chronic diseases in the United States, 1986R A Hahn, S M Teutsch, R B Rothenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injuryR A Hahn, B R MacDonald, M Chastain, et al.
Journal of the American Medical Women'S Association (1972)|May 22, 1998
The prevalence of risk factors among women in the United States by race and age, 1992-1994: opportunities for primary and secondary preventionR A Hahn, S M Teutsch, A L Franks, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1990
Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct sizeR A Hahn, B R MacDonald, P J Simpson, et al.
American Journal of Public Health|April 1, 1989
Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic studyR A Hahn, L S Magder, S O Aral, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1972
Cardiovascular effects of veronamineR A Hahn, M G Kelly, M Shamma, et al.
The Journal of Cell Biology|December 1, 1996
Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphologyJ K Marchant, R A Hahn, T F Linsenmayer, et al.
Biochemical Pharmacology|October 1, 1984
Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)R W Fuller, R A Hahn, H D Snoddy, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 1, 1996
Characterization of collagen fibril segments from chicken embryo cornea, dermis and tendonD E Birk, R A Hahn, C Y Linsenmayer, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonistR A Hahn, J R Wardell, H M Sarau, et al.
JAMA|November 28, 1990
Excess deaths from nine chronic diseases in the United States, 1986R A Hahn, S M Teutsch, R B Rothenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injuryR A Hahn, B R MacDonald, M Chastain, et al.
Journal of the American Medical Women'S Association (1972)|May 22, 1998
The prevalence of risk factors among women in the United States by race and age, 1992-1994: opportunities for primary and secondary preventionR A Hahn, S M Teutsch, A L Franks, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1990
Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct sizeR A Hahn, B R MacDonald, P J Simpson, et al.
American Journal of Public Health|April 1, 1989
Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic studyR A Hahn, L S Magder, S O Aral, et al.
Pageof 7